“For Dr. Joseph Cacchione, the math on GLP-1 drugs stopped making sense. The C.E.O. of the Philadelphia-based nonprofit hospital system Jefferson said his organization now spends more on prescription drug coverage — fueled by the soaring use of weight loss medications like Wegovy and Zepbound — than it does on inpatient care,” Berkeley Lovelace Jr., Jessica Herzberg and Anne Thompson write over […]
